Yang Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yang Fu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Yiyu Qin
Department of Translational Medicine Jiangsu Medical College 283 South of Republic Road Yancheng 224005 China
2 shared publications - Anxing Ge
Department of Science and Technology, Jiangsu Vocational College of Medicine, Yancheng, Jiangsu, 224005, PR China
1 shared publication Changqing Guo
Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
1 shared publicationGe Yang
Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
1 shared publication- Haiyan Shi
Clinical Medical College, Jiangsu Vocational College of Medicine, Yancheng, Jiangsu, 224005, PR China
1 shared publication - Li Chang
Clinical Medical College, Jiangsu Vocational College of Medicine, Yancheng, Jiangsu, 224005, PR China
1 shared publication
Latest Publications
- Open Access
- 1 October 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 118, 109266
Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo
- 1 October 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 118, 109266
Open AccessOverexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo
- Open Access
- 30 August 2019
- Published by Wiley in Molecular Carcinogenesis
- Vol. 58 (11) , 2104-2117
Small nucleolar RNA host gene 1 promotes development and progression of colorectal cancer through negative regulation of miR‐137
Small nucleolar RNA host gene 1 (SNHG1) is critical in the progression of cancers. However, the mechanism by which SNHG1 regulates the progression of colorectal cancer (CRC) remains unclear. Expressions of SNHG1 and miR‐137 in CRC tissues and cell lines were evaluated by quantitative real‐time polymerase chain reaction. A luciferase reporter gene assay was conducted to investigate miR‐137 target. Additionally, RNA pull‐down assay was performed to explore the physical association between miR‐137, SNHG1, and RNA induced silencing complex (RISC). Cell cycling and invasion were examined by flow cytometry (FCM) and transwell assays. The in vivo carcinogenic activity of SNHG1 was examined using murine xenograft models. Expression of RICTOR, serine/threonine kinase 1 (AKT), serum and glucocorticoid‐inducible kinase 1 (SGK1), p70S6K1, and LC3II/LC3I ratio was examined by Western blot analysis. SNHG1 upregulation was observed in CRC tissues and cell lines, which was associated with the lymph node metastasis, advanced TNM stage and poorer prognosis. SNHG1 increased RICTOR level in CRC via sponging miR‐137. In addition, SNHG1 silencing inhibited CRC cell proliferation and migration in vitro and in vivo. SNHG1 regulated RICTOR expression by sponging miR‐137 and promoted tumorgenesis in CRC.
- 30 August 2019
- Published by Wiley in Molecular Carcinogenesis
- Vol. 58 (11) , 2104-2117
Open AccessSmall nucleolar RNA host gene 1 promotes development and progression of colorectal cancer through negative regulation of miR‐137
Small nucleolar RNA host gene 1 (SNHG1) is critical in the progression of cancers. However, the mechanism by which SNHG1 regulates the progression of colorectal cancer (CRC) remains unclear. Expressions of SNHG1 and miR‐137 in CRC tissues and cell lines were evaluated by quantitative real‐time polymerase chain reaction. A luciferase reporter gene assay was conducted to investigate miR‐137 target. Additionally, RNA pull‐down assay was performed to explore the physical association between miR‐137, SNHG1, and RNA induced silencing complex (RISC). Cell cycling and invasion were examined by flow cytometry (FCM) and transwell assays. The in vivo carcinogenic activity of SNHG1 was examined using murine xenograft models. Expression of RICTOR, serine/threonine kinase 1 (AKT), serum and glucocorticoid‐inducible kinase 1 (SGK1), p70S6K1, and LC3II/LC3I ratio was examined by Western blot analysis. SNHG1 upregulation was observed in CRC tissues and cell lines, which was associated with the lymph node metastasis, advanced TNM stage and poorer prognosis. SNHG1 increased RICTOR level in CRC via sponging miR‐137. In addition, SNHG1 silencing inhibited CRC cell proliferation and migration in vitro and in vivo. SNHG1 regulated RICTOR expression by sponging miR‐137 and promoted tumorgenesis in CRC.